OBJECTIVES: To compare longitudinal patterns of health care utilization and quality of care for other health conditions between breast cancer-surviving older women and a matched cohort without breast cancer. DESIGN: Prospective five-year longitudinal comparison of cases and matched controls. SUBJECTS: Newly identified breast cancer patients recruited during 1997-1999 from four geographic regions (Los Angeles, CA; Minnesota; North Carolina; and Rhode Island; N = 422) were matched by age, race, baseline comorbidity and zip code location with up to four non-breast-cancer controls (N = 1,656). OUTCOMES: Survival; numbers of hospitalized days and physician visits; total inpatient and outpatient Medicare payments; guideline monitoring for patients with cardiovascular disease and diabetes, and bone density testing and colorectal cancer screening. RESULTS: Five-year survival was similar for cases and controls (80% and 82%, respectively; p = 0.18). In the first follow-up year, comorbidity burden and health care utilization were higher for cases (p < 0.01), with most differences diminishing over time. However, the number of physician visits was higher for cases (p < 0.01) in every year, driven partly by more cancer and surgical specialist visits. Cases and controls adhered similarly to recommended bone density testing, and monitoring of cardiovascular disease and diabetes; adherence to recommended colorectal cancer screening was better among cases. CONCLUSION: Breast cancer survivors' health care utilization and disease burden return to pre-diagnosis levels after one year, yet their greater use of outpatient care persists at least five years. Quality of care for other chronic health problems is similar for cases and controls.
OBJECTIVES: To compare longitudinal patterns of health care utilization and quality of care for other health conditions between breast cancer-surviving older women and a matched cohort without breast cancer. DESIGN: Prospective five-year longitudinal comparison of cases and matched controls. SUBJECTS: Newly identified breast cancerpatients recruited during 1997-1999 from four geographic regions (Los Angeles, CA; Minnesota; North Carolina; and Rhode Island; N = 422) were matched by age, race, baseline comorbidity and zip code location with up to four non-breast-cancer controls (N = 1,656). OUTCOMES: Survival; numbers of hospitalized days and physician visits; total inpatient and outpatient Medicare payments; guideline monitoring for patients with cardiovascular disease and diabetes, and bone density testing and colorectal cancer screening. RESULTS: Five-year survival was similar for cases and controls (80% and 82%, respectively; p = 0.18). In the first follow-up year, comorbidity burden and health care utilization were higher for cases (p < 0.01), with most differences diminishing over time. However, the number of physician visits was higher for cases (p < 0.01) in every year, driven partly by more cancer and surgical specialist visits. Cases and controls adhered similarly to recommended bone density testing, and monitoring of cardiovascular disease and diabetes; adherence to recommended colorectal cancer screening was better among cases. CONCLUSION:Breast cancer survivors' health care utilization and disease burden return to pre-diagnosis levels after one year, yet their greater use of outpatient care persists at least five years. Quality of care for other chronic health problems is similar for cases and controls.
Authors: Rebecca A Silliman; Edward Guadagnoli; William Rakowski; Mary Beth Landrum; Timothy L Lash; Robert Wolf; Aliza Fink; Patricia A Ganz; Jerry Gurwitz; Catherine Borbas; Vincent Mor Journal: J Clin Oncol Date: 2002-06-01 Impact factor: 44.544
Authors: Joan L Warren; Martin L Brown; Michael P Fay; Nicola Schussler; Arnold L Potosky; Gerald F Riley Journal: J Clin Oncol Date: 2002-01-01 Impact factor: 44.544
Authors: Arlene S Ash; Michael A Posner; Jeanne Speckman; Shakira Franco; Andrew C Yacht; Lindsey Bramwell Journal: Health Serv Res Date: 2003-10 Impact factor: 3.402
Authors: Claire F Snyder; Kevin D Frick; Kimberly S Peairs; Melinda E Kantsiper; Robert J Herbert; Amanda L Blackford; Antonio C Wolff; Craig C Earle Journal: J Gen Intern Med Date: 2009-01-21 Impact factor: 5.128
Authors: Brenna E Blackburn; Patricia A Ganz; Kerry Rowe; John Snyder; Yuan Wan; Vikrant Deshmukh; Michael Newman; Alison Fraser; Ken Smith; Kimberly Herget; Jaewhan Kim; Anne C Kirchhoff; Christina Porucznik; Heidi Hanson; Marcus Monroe; Mia Hashibe Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-11-22 Impact factor: 4.254
Authors: Jennifer H Jordan; Soe Soe Thwin; Timothy L Lash; Diana S M Buist; Terry S Field; Reina Haque; Pamala A Pawloski; Hans V Petersen; Marianne N Prout; Virginia P Quinn; Marianne Ulcickas Yood; Rebecca A Silliman; Ann M Geiger Journal: Breast Cancer Res Treat Date: 2014-06-18 Impact factor: 4.872
Authors: Racquel E Kohler; Ravi K Goyal; Kristen Hassmiller Lich; Marisa Elena Domino; Stephanie B Wheeler Journal: Cancer Date: 2015-08-19 Impact factor: 6.860
Authors: Leigh Anne Faul; Gheorghe Luta; Vanessa Sheppard; Claudine Isaacs; Harvey J Cohen; Hyman B Muss; Rachel Yung; Jonathan D Clapp; Eric Winer; Clifford Hudis; Michelle Tallarico; Julhy Wang; William T Barry; Jeanne S Mandelblatt Journal: J Cancer Surviv Date: 2014-06-11 Impact factor: 4.442